Literature DB >> 18433817

Genetic variability of aryl hydrocarbon receptor (AhR)-mediated regulation of the human UDP glucuronosyltransferase (UGT) 1A4 gene.

Thomas J Erichsen1, Ursula Ehmer, Sandra Kalthoff, Tim O Lankisch, Tordis M Müller, Peter A Munzel, Michael P Manns, Christian P Strassburg.   

Abstract

UDP glucuronosyltransferases (UGTs) play an important role for drug detoxification and toxicity. UGT function is genetically modulated by single nucleotide polymorphisms (SNPs) which lead to the expression of functionally altered protein, or altered expression levels. UGT1A4 activity includes anticonvulsants, antidepressants and environmental mutagens. In this study the induction of the human UGT1A4 gene and a potential influence of genetic variation in its promoter region were analyzed. SNPs at bp -219 and -163 occurred in 9% among 109 blood donors reducing UGT1A4 transcription by 40%. UGT1A4 transcription was dioxin inducible. Reporter gene experiments identified 2 xenobiotic response elements (XRE), which were functionally confirmed by mutagenesis analyses, and binding was demonstrated by electromobility shift assays. Constitutive human UGT1A4 gene expression and induction was aryl hydrocarbon receptor (AhR)-dependent, and reduced in the presence of SNPs at bp -219 and -163. AhR-mediated regulation of the human UGT1A4 gene by two XRE and a modulation by naturally occurring genetic variability by SNPs is demonstrated, which indicates gene-environment interaction with potential relevance for drug metabolism.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18433817     DOI: 10.1016/j.taap.2008.02.020

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN: 0041-008X            Impact factor:   4.219


  17 in total

1.  Effects of cigarette smoke on the human oral mucosal transcriptome.

Authors:  Jay O Boyle; Zeynep H Gümüs; Ashutosh Kacker; Vishal L Choksi; Jennifer M Bocker; Xi Kathy Zhou; Rhonda K Yantiss; Duncan B Hughes; Baoheng Du; Benjamin L Judson; Kotha Subbaramaiah; Andrew J Dannenberg
Journal:  Cancer Prev Res (Phila)       Date:  2010-02-23

2.  Studies on induction of lamotrigine metabolism in transgenic UGT1 mice.

Authors:  U A Argikar; K Senekeo-Effenberger; E E Larson; R H Tukey; R P Remmel
Journal:  Xenobiotica       Date:  2009-11       Impact factor: 1.908

3.  Carriers of the UGT1A4 142T>G gene variant are predisposed to reduced olanzapine exposure--an impact similar to male gender or smoking in schizophrenic patients.

Authors:  Roza Ghotbi; Buster Mannheimer; Eleni Aklillu; Akira Suda; Leif Bertilsson; Erik Eliasson; Urban Osby
Journal:  Eur J Clin Pharmacol       Date:  2010-02-09       Impact factor: 2.953

4.  Effect of MRP2 and MRP3 Polymorphisms on Anastrozole Glucuronidation and MRP2 and MRP3 Gene Expression in Normal Liver Samples.

Authors:  Vineetha Koroth Edavana; Rosalind B Penney; Aiwei Yao-Borengasser; Athena Starlard-Davenport; Ishwori B Dhakal; Susan Kadlubar
Journal:  Int J Cancer Res Mol Mech       Date:  2015-09-22

Review 5.  Activation of xenobiotic receptors: driving into the nucleus.

Authors:  Haishan Li; Hongbing Wang
Journal:  Expert Opin Drug Metab Toxicol       Date:  2010-04       Impact factor: 4.481

6.  Regulation of aryl hydrocarbon receptor function by selective estrogen receptor modulators.

Authors:  Carolyn D DuSell; Erik R Nelson; Bryan M Wittmann; Jackie A Fretz; Dmitri Kazmin; Russell S Thomas; J Wesley Pike; Donald P McDonnell
Journal:  Mol Endocrinol       Date:  2009-11-09

7.  Interaction between oxidative stress sensor Nrf2 and xenobiotic-activated aryl hydrocarbon receptor in the regulation of the human phase II detoxifying UDP-glucuronosyltransferase 1A10.

Authors:  Sandra Kalthoff; Ursula Ehmer; Nicole Freiberg; Michael P Manns; Christian P Strassburg
Journal:  J Biol Chem       Date:  2010-01-06       Impact factor: 5.157

8.  Potential role of UGT1A4 promoter SNPs in anastrozole pharmacogenomics.

Authors:  Vineetha Koroth Edavana; Ishwori B Dhakal; Suzanne Williams; Rosalind Penney; Gunnar Boysen; Aiwei Yao-Borengasser; Susan Kadlubar
Journal:  Drug Metab Dispos       Date:  2013-01-31       Impact factor: 3.922

9.  Pharmacogenetics of UGT1A4, UGT2B7 and UGT2B15 and Their Influence on Tamoxifen Disposition in Asian Breast Cancer Patients.

Authors:  Natalia Sutiman; Joanne Siok Liu Lim; Thomas E Muerdter; Onkar Singh; Yin Bun Cheung; Raymond Chee Hui Ng; Yoon Sim Yap; Nan Soon Wong; Peter Cher Siang Ang; Rebecca Dent; Werner Schroth; Matthias Schwab; Chiea Chuen Khor; Balram Chowbay
Journal:  Clin Pharmacokinet       Date:  2016-10       Impact factor: 6.447

10.  A pharmacogenetics study of the human glucuronosyltransferase UGT1A4.

Authors:  Marie-Odile Benoit-Biancamano; Jean-Philippe Adam; Olivier Bernard; Michael H Court; Marie-Hélène Leblanc; Patrick Caron; Chantal Guillemette
Journal:  Pharmacogenet Genomics       Date:  2009-12       Impact factor: 2.089

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.